new_0222_0603|SNSE|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0603|SNSE|1|Sensei Biotherapeutics Inc Total Current Assets (Quarterly) (USD)|Sensei Biotherapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Sensei Biotherapeutics Inc Inventories (Quarterly) (USD)|Sensei Biotherapeutics Inc Net PP&E (Quarterly) (USD)|Sensei Biotherapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Liabilities (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Current Liabilities (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Deposits (Quarterly) (USD)|Sensei Biotherapeutics Inc Book Value (Quarterly) (USD)|Sensei Biotherapeutics Inc Retained Earnings (Quarterly) (USD)|Sensei Biotherapeutics Inc Treasury Stock (Quarterly) (USD)|Sensei Biotherapeutics Inc EV to Revenues|Sensei Biotherapeutics Inc EV to Earnings|Sensei Biotherapeutics Inc EV to Free Cash Flow|Sensei Biotherapeutics Inc EV to Assets (Quarterly)|Sensei Biotherapeutics Inc PS Ratio|Sensei Biotherapeutics Inc PE Ratio|Sensei Biotherapeutics Inc Price to Book Value|Sensei Biotherapeutics Inc PEG Ratio|Sensei Biotherapeutics Inc Debt to Equity Ratio|Sensei Biotherapeutics Inc Dividend Yield|Sensei Biotherapeutics Inc Shareholder Yield (TTM)|Sensei Biotherapeutics Inc Percent of Shares Outstanding Short|Sensei Biotherapeutics Inc Total Receivables (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Payables (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Capital Stock (Quarterly) (USD)|Sensei Biotherapeutics Inc Return on Invested Capital|Sensei Biotherapeutics Inc Quality Ratio Score|Sensei Biotherapeutics Inc Momentum Score|Sensei Biotherapeutics Inc Beta (1Y)|Sensei Biotherapeutics Inc Sustainable Growth Rate (TTM)|Sensei Biotherapeutics Inc Institutional Investor Ownership Percentage|Sensei Biotherapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Sensei Biotherapeutics Inc Total Employees (Annual)|Sensei Biotherapeutics Inc EPS Diluted (Quarterly) (USD)|Sensei Biotherapeutics Inc Shares Outstanding|Sensei Biotherapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Sensei Biotherapeutics Inc Ordinary Shares Number (Quarterly)|Sensei Biotherapeutics Inc Payout Ratio|Sensei Biotherapeutics Inc Quick Ratio (Quarterly)|Sensei Biotherapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Sensei Biotherapeutics Inc Stock Buybacks (Quarterly) (USD)|Sensei Biotherapeutics Inc Effective Tax Rate (TTM)|Sensei Biotherapeutics Inc Return on Equity|Sensei Biotherapeutics Inc Net Income (TTM) (USD)|Sensei Biotherapeutics Inc Revenue (TTM) (USD)|Sensei Biotherapeutics Inc Dividend Per Share (Quarterly) (USD)|Sensei Biotherapeutics Inc Revenue (Quarterly) (USD)|Sensei Biotherapeutics Inc Gross Profit (Quarterly) (USD)|Sensei Biotherapeutics Inc SG&A Expense (Quarterly) (USD)|Sensei Biotherapeutics Inc Pre-Tax Income (Quarterly) (USD)|Sensei Biotherapeutics Inc Net Income (Quarterly) (USD)|Sensei Biotherapeutics Inc Net Interest Income (Quarterly) (USD)|Sensei Biotherapeutics Inc Price (USD)|Sensei Biotherapeutics Inc Total Return Price (USD)|Sensei Biotherapeutics Inc Enterprise Value (USD)|Sensei Biotherapeutics Inc 30-Day Average Daily Volume|Sensei Biotherapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0603|SNSE|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0603|SNSE|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0603|SNSE|5|121.833333333|121.833333333||121.833333333||121.833333333|121.833333333|121.833333333||121.833333333|121.833333333||||1.44326241135||||1.44262295082|||1.44326241135||15.24||121.833333333|121.833333333||||||30.4166666667|91.375|228.5|91.375|33.25||121.833333333|||91.375|91.4285714286|||91.4|||||91.375|91.375|91.375|91.375|1.44326241135|1.44326241135|1.44326241135|1.44268774704|1.44827586207||
new_0222_0603|SNSE|6|6|6||6||6|6|6||6|6||||282||||244|||282||25||6|6||||||12|8|2|8|12||6|||8|7|||5|||||8|8|8|8|282|282|282|253|29||
new_0222_0603|SNSE|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0603|SNSE|201912|0.502|0.251||0.268||69.879|21.714|48.165||-68.662|-92.312|||||||||||||||3.547||||||||12.3166||-0.6216|||29.5583|||-0.39|||||||||0.982|-6.705|-6.705|-1.396|||||||
new_0222_0603|SNSE|202003||||||||||||||||||||||||||||||||||12.3166||-0.3894||||||-0.4654|||||||||1.908|-4.692|-4.692|-1.629|||||||
new_0222_0603|SNSE|202006||||||||||||||||||||||||||||||||||12.3166||-0.3987||||||-0.3387|||||||||1.311|-4.91|-4.91|-0.003|||||||
new_0222_0603|SNSE|202009|4.429|3.733||1.05||57.196|4.715|52.481||-51.681|-107.281|||||||||||||||0.974||||||||12.3166|25|-0.4358|||29.5583|||-0.4358||||-21.674|||||1.788|-5.367|-5.367|-0.003|||||||
new_0222_0603|SNSE|202012|20.076|16.596||1.266||77.871|4.83|73.041||-56.443|-112.412||||-25.8411|||||||||1.3327||3.882|||||||24.62|29.5583|32|-0.1736|30.5885||29.5583|||-0.1736||||-20.1|||||2.521|-5.131|-5.131|-0.054|16.5|16.5|488.6813||||
new_0222_0603|SNSE|202103|172.785|169.418||1.655||3.224|2.475|0.749||171.252|-120.384||||-11.6518||||2.5953|||||1.8685|||0.003||||||43.695|18.9049||-0.42|30.5885||30.5885|||-0.42|-140.594|||-23.38|||||4.604|-7.972|-7.972|-0.003|14.53|14.53|275.5999|208264.2||13.24|12.43
new_0222_0603|SNSE|202106|165.613|162.498||2.111||4.599|3.923|0.676||163.125|-130.155||||-4.9593||||1.8302|||||0.7226|||0.003||||||36.6299|30.5885||-0.32|30.5885||30.5885|||-0.3191||||-28.241|||||3.886|-9.771|-9.771|0.041|9.76|9.76|136.6128|175800.3333||7.89|10.78
new_0222_0603|SNSE|202109|158.162|156.662||3.06||6.041|5.264|0.777||155.208|-139.84||||-6.1437||||2.0733|||||1.7192|||0.003||||||45.1997|30.5885||-0.32|30.5885||30.5885|||-0.3385||||-32.559|||||3.873|-9.685|-9.685|0.064|10.52|10.52|165.129|173620.1||8.69|6.88
new_0222_0603|SNSE|202112|148.542|147.621||4.644||6.712|4.889|1.823||146.513|-149.206||||-0.9265||||1.2117|||||1.094||2.456|0.003||||||49.7382|30.6325|56|-0.3|30.609||30.609|||-0.3006||||-36.794|||||3.457|-9.366|-9.366|0.028|5.8|5.8|29.9112|111706.7|-78.1212|4.82|3.61
new_0222_0603|SNSE|202203|||||||||||||||1.9019||||0.5885||||||||||||||||||30.6828||||||||||||||||||2.81|2.81|-61.4023|69771.1333|-81.8827||